Antiviral activity of a chemically stabilized 2-5A analog upon microinjection into HeLa cells

FEBS Lett. 1986 Mar 31;198(2):326-32. doi: 10.1016/0014-5793(86)80430-6.

Abstract

2-5A[ppp(A2'p)n5'A] has been implicated as a mediator in the antiviral action of interferon. Its direct evaluation as an indicator of virus replication is hampered by two limitations: its inability to penetrate intact cells, and its rapid intracellular degradation by (2'-5')phosphodiesterase. These problems could be overcome by using a microinjection technique whereby a phosphodiesterase-resistant analog of 2-A, in which the 2'-terminals adenosine residue is replaced by 2-(9-adenyl)-6-hydroxy-methyl-4-hexylmorpholine, was injected into individual HeLa cells before infection with mengovirus or vesicular stomatitis virus (VSV). This comparative assay with two representatives of different virus classes in a single experimental system pointed to the high sensitivity of VSV to inhibition by 2-5A oligonucleotides, in contrast with the low sensitivity of mengovirus. Microinjection of the hexylmorpholine 2-5A analog led to a much greater reduction in mengovirus yield than did microinjection of 2-5A itself.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenine Nucleotides / pharmacology*
  • Antiviral Agents / pharmacology*
  • Dose-Response Relationship, Drug
  • HeLa Cells
  • Humans
  • Interferons / pharmacology
  • Mengovirus / drug effects
  • Microinjections
  • Oligoribonucleotides / pharmacology*
  • Vesicular stomatitis Indiana virus / drug effects
  • Virus Replication / drug effects

Substances

  • Adenine Nucleotides
  • Antiviral Agents
  • Oligoribonucleotides
  • 2',5'-oligoadenylate
  • Interferons